Quantitative Imaging Workshop


QIW: What it is and why it’s important…


View 2022 Workshop materials

Workshop One-pager (PDF, 261 KB)

Goals and history of the Workshop

QIW XIX In the News: ASCO Post Articles, December 2022


This year’s Quantitative Imaging Workshop featured early detection of lung cancer, COPD and cardiovascular disease through thoracic imaging as a cornerstone of effective public health. Sessions covered pragmatic issues with thoracic screening to accelerate the implementation of lung cancer screening, evolving innovations in early detection technology, issues related to health equity and the refinement of imaging to enable the transition to population health.

Since 2004, the Quantitative Imaging Workshop focuses on the advancement of quantitative low-dose computerized tomography (LDCT) imaging biomarkers for detection and management of early thoracic disease—lung cancer, COPD and cardiovascular disease—three of the top four leading causes of death in the U.S.

Beginning in 2013, each year at the Workshop the Prevent Cancer Foundation® presents the James L. Mulshine, M.D., National Leadership Award to an individual who has had a profound impact on reducing the toll these diseases take on the health of Americans and individuals around the world.

The 2022 James L. Mulshine, M.D., National Leadership Award honored Andrea B. McKee, M.D. and the late Brady J. McKee, M.D. for their contributions to ensuring community hospitals and cancer centers provide equitable access to the highest quality screenings. Drs. Andrea and Brady McKee were instrumental in developing the LungRADS system, a quality assurance tool to standardize lung cancer screening reporting and management recommendations and facilitate outcome monitoring.

Past recipients of this award include:

  • 2021 – Mary Pasquinelli, DNP, APRN, FNP-BC, CTTS, for her work to advance lung cancer screening through patient care, research, and publication.
  • 2020 – Daniel C. Sullivan, M.D. for his work in founding and chairing the Quantitative Imaging Biomarkers Alliance (QIBA). QIBA is committed to transforming patient care by making radiology a more quantitative science.
  • 2019 – Andrew C. von Eschenbach, M.D., Director, National Cancer Institute, for his design, implementation and management of the largest and most expensive clinical trial in its history, the National Lung Screening Trial (NLST)
  • 2018 – Sharon Y. Eubanks, U.S. Department of Justice, for her work as the lead Justice Department prosecutor in the landmark racketeering trial against Big Tobacco, a case which defied predictions and was won by the government
  • 2017 – The late John Walsh, President and CEO of the COPD Foundation and President and Founder of the Alpha One Foundation
  • 2016 – Laurie Fenton Ambrose, President and CEO of the Lung Cancer Alliance, for her efforts to guide patient advocacy groups in successful efforts to gain coverage of lung cancer screening by the Centers for Medicare & Medicaid Services (CMS)
  • 2015 – Claudia Henschke, Ph.D., M.D., Mt. Sinai Medical Center, as a pioneer of the use of low-dose spiral CT to screen for lung cancer
  • 2014 – CVS Health, award accepted by Nancy Gagliano, M.D., CVS Chief Medical Officer, in recognition of the company’s bold decision to discontinue the sale of tobacco products in their stores
  • 2013 (Inaugural year of the Award) – Cheryl G. Healton, Ph.D., President and CEO, Legacy Foundation and Dean of the College of Public Health at New York University, in recognition of over 25 years of tireless work in public health, specifically on tobacco control

Support the Quantitative Imaging Workshop  

The Prevent Cancer Foundation® values its partnerships with its supporters and appreciates the impact we make together on increasing cancer screening and early detection. If your organization would like to support the Quantitative Imaging Workshop, or for more information on how you can become a corporate partner, please contact Becca Ginns at

Special thanks to the 2022 Quantitative Imaging Workshop XIX supporters!


American Lung Association Bristol Myers Squibb Lung Cancer Initiative at Johnson & Johnson Median Technologies


Sign up to get the latest about cancer prevention and early detection directly in your inbox.